Home > Research > Publications & Outputs > The clinical and lifestyle determinants of seru...
View graph of relations

The clinical and lifestyle determinants of serum HDL-c, apolipoprotein A-1, paraoxonase-1 activity and oxidised LDL in healthy, medication naive middle-aged adults.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The clinical and lifestyle determinants of serum HDL-c, apolipoprotein A-1, paraoxonase-1 activity and oxidised LDL in healthy, medication naive middle-aged adults. / Hobkirk, James P; Soran, Handrean; Swainson, Michelle et al.
In: Atherosclerosis, Vol. 236, No. 2, 10.2014, p. e305.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Hobkirk JP, Soran H, Swainson M, Pemberton P, Carroll S. The clinical and lifestyle determinants of serum HDL-c, apolipoprotein A-1, paraoxonase-1 activity and oxidised LDL in healthy, medication naive middle-aged adults. Atherosclerosis. 2014 Oct;236(2):e305. doi: 10.1016/j.atherosclerosis.2014.08.006

Author

Bibtex

@article{6ef314019a7e4689ae41913e603a670d,
title = "The clinical and lifestyle determinants of serum HDL-c, apolipoprotein A-1, paraoxonase-1 activity and oxidised LDL in healthy, medication naive middle-aged adults.",
abstract = "Introduction: HDL cholesterol may underestimate the anti-oxidative potential of HDL. HDL anti-oxidative potential is mediated by PON-1, which metabolises lipid peroxides and impacts on oxidised LDL (ox-LDL) concentrations. We sought to investigate the determinants of HDL-c, apo A-I and PON-1 activity and to ascertain whether HDL-c, apo A-I, PON-1 activity could explain the variance of ox-LDL concentrations in a sub-group of high PON-1 activity (n=22) >230 or low (n=22) <63 nmol/min/ml participants. Methods: 221 (72% male) participants were assessed during health assessments at Nuffield Health Medical Centre in Manchester. Participants avoided vigorous physical activity and alcohol 24 hours prior to assessment. Lifestyle factors including smoking status, alcohol intake and physical activity and cardio-respiratory fitness were assesssed. Participants with CVD or T2D were excluded. Fasting blood was taken to measure HDL-c, PON-1 activity, apo AI and ox-LDL and other blood variables. Correlations and regression analysis assessed inter-relationships and determinants of HDL-c, apo A-1, PON-1 activity and ox-LDL. Regression models included age, sex, waist, TG, alcohol, physical activity, fitness, hs-CRP and QRISK. Results: The correlation between PON-1 activity and HDL-c (r=0.12), apo A-I (r=0.11) were non-significant. Waist circumference, TG, alcohol intake, sex and fitness were predictors of HDL-c, accounting for 40.3% of the variance. Waist circumference, TG and alcohol predicted apo A-I concentrations, accounting for 13.1% of the variance. None of the variables measured predicted PON-1 activity. Ox-LDL was not significantly correlated with HDL-c (r=0-.19) apo A-I (r=-0.20) or PON-1 activity (r=0.09) but was to TG (r=0.69, p<0.001). Furthermore, TG (52%), hs-CRP (7.4%) and age (6.6%) accounted for 66% of the variance in ox-LDL. Discussion: PON-1 activity did not correlate with any clinical or lifestyle variables. Concentrations of ox-LDL were strongly related to TG concentrations. Lifestyle factors that regulate TG metabolism are an important therapy to decrease highly atherogenic ox-LDL particles.",
author = "Hobkirk, {James P} and Handrean Soran and Michelle Swainson and Philip Pemberton and Sean Carroll",
year = "2014",
month = oct,
doi = "10.1016/j.atherosclerosis.2014.08.006",
language = "English",
volume = "236",
pages = "e305",
journal = "Atherosclerosis",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - The clinical and lifestyle determinants of serum HDL-c, apolipoprotein A-1, paraoxonase-1 activity and oxidised LDL in healthy, medication naive middle-aged adults.

AU - Hobkirk, James P

AU - Soran, Handrean

AU - Swainson, Michelle

AU - Pemberton, Philip

AU - Carroll, Sean

PY - 2014/10

Y1 - 2014/10

N2 - Introduction: HDL cholesterol may underestimate the anti-oxidative potential of HDL. HDL anti-oxidative potential is mediated by PON-1, which metabolises lipid peroxides and impacts on oxidised LDL (ox-LDL) concentrations. We sought to investigate the determinants of HDL-c, apo A-I and PON-1 activity and to ascertain whether HDL-c, apo A-I, PON-1 activity could explain the variance of ox-LDL concentrations in a sub-group of high PON-1 activity (n=22) >230 or low (n=22) <63 nmol/min/ml participants. Methods: 221 (72% male) participants were assessed during health assessments at Nuffield Health Medical Centre in Manchester. Participants avoided vigorous physical activity and alcohol 24 hours prior to assessment. Lifestyle factors including smoking status, alcohol intake and physical activity and cardio-respiratory fitness were assesssed. Participants with CVD or T2D were excluded. Fasting blood was taken to measure HDL-c, PON-1 activity, apo AI and ox-LDL and other blood variables. Correlations and regression analysis assessed inter-relationships and determinants of HDL-c, apo A-1, PON-1 activity and ox-LDL. Regression models included age, sex, waist, TG, alcohol, physical activity, fitness, hs-CRP and QRISK. Results: The correlation between PON-1 activity and HDL-c (r=0.12), apo A-I (r=0.11) were non-significant. Waist circumference, TG, alcohol intake, sex and fitness were predictors of HDL-c, accounting for 40.3% of the variance. Waist circumference, TG and alcohol predicted apo A-I concentrations, accounting for 13.1% of the variance. None of the variables measured predicted PON-1 activity. Ox-LDL was not significantly correlated with HDL-c (r=0-.19) apo A-I (r=-0.20) or PON-1 activity (r=0.09) but was to TG (r=0.69, p<0.001). Furthermore, TG (52%), hs-CRP (7.4%) and age (6.6%) accounted for 66% of the variance in ox-LDL. Discussion: PON-1 activity did not correlate with any clinical or lifestyle variables. Concentrations of ox-LDL were strongly related to TG concentrations. Lifestyle factors that regulate TG metabolism are an important therapy to decrease highly atherogenic ox-LDL particles.

AB - Introduction: HDL cholesterol may underestimate the anti-oxidative potential of HDL. HDL anti-oxidative potential is mediated by PON-1, which metabolises lipid peroxides and impacts on oxidised LDL (ox-LDL) concentrations. We sought to investigate the determinants of HDL-c, apo A-I and PON-1 activity and to ascertain whether HDL-c, apo A-I, PON-1 activity could explain the variance of ox-LDL concentrations in a sub-group of high PON-1 activity (n=22) >230 or low (n=22) <63 nmol/min/ml participants. Methods: 221 (72% male) participants were assessed during health assessments at Nuffield Health Medical Centre in Manchester. Participants avoided vigorous physical activity and alcohol 24 hours prior to assessment. Lifestyle factors including smoking status, alcohol intake and physical activity and cardio-respiratory fitness were assesssed. Participants with CVD or T2D were excluded. Fasting blood was taken to measure HDL-c, PON-1 activity, apo AI and ox-LDL and other blood variables. Correlations and regression analysis assessed inter-relationships and determinants of HDL-c, apo A-1, PON-1 activity and ox-LDL. Regression models included age, sex, waist, TG, alcohol, physical activity, fitness, hs-CRP and QRISK. Results: The correlation between PON-1 activity and HDL-c (r=0.12), apo A-I (r=0.11) were non-significant. Waist circumference, TG, alcohol intake, sex and fitness were predictors of HDL-c, accounting for 40.3% of the variance. Waist circumference, TG and alcohol predicted apo A-I concentrations, accounting for 13.1% of the variance. None of the variables measured predicted PON-1 activity. Ox-LDL was not significantly correlated with HDL-c (r=0-.19) apo A-I (r=-0.20) or PON-1 activity (r=0.09) but was to TG (r=0.69, p<0.001). Furthermore, TG (52%), hs-CRP (7.4%) and age (6.6%) accounted for 66% of the variance in ox-LDL. Discussion: PON-1 activity did not correlate with any clinical or lifestyle variables. Concentrations of ox-LDL were strongly related to TG concentrations. Lifestyle factors that regulate TG metabolism are an important therapy to decrease highly atherogenic ox-LDL particles.

U2 - 10.1016/j.atherosclerosis.2014.08.006

DO - 10.1016/j.atherosclerosis.2014.08.006

M3 - Journal article

VL - 236

SP - e305

JO - Atherosclerosis

JF - Atherosclerosis

IS - 2

ER -